Page
%P
-
Article
Open AccessEarly and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodies
Six to 19% of critically ill COVID-19 patients display circulating auto-antibodies against type I interferons (IFN-AABs). Here, we establish a clinically applicable strategy for early identification of IFN-AAB...